Home » Topics » Regulatory

Regulatory
RSS

Potential new indication for zafirlukast in the treatment of urticaria

March 23, 1998

First market introduction for Allegra-D

March 16, 1998

FDA approves low-dose Estratab for osteoporosis

March 13, 1998

FDA approves three-day treatment option for bacterial vaginosis

March 12, 1998

Diovan HCT approved in U.S.

March 11, 1998

FDA approves ocular antiinflammatory agent

March 11, 1998

Cipro HC approved for otitis

March 10, 1998

First approval for RPR's new combination patch

March 10, 1998

New cisapride formulation introduced in U.K.

March 9, 1998

Once-a-day Cozaar introduced in Canada

March 9, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
DEE-lightful: Praxis’ phase II results allow stock to flex its muscle
BioWorld
Positive efficacy results led to Praxis Precision Medicines Inc.’s phase II Embold study in developmental and epileptic encephalopathies (DEEs) being halted...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...